Jabil: Margin Expansion Is Just Beginning

Jabil is rated Buy with a $450 price target, implying 32% upside driven by AI infrastructure demand and margin expansion. Operating margin is expected to rise from 5.7% in FY26 to above 6% in FY27, supporting EPS compounding. The company’s diversified portfolio, capacity expansion, and third hyperscaler win position it as a key beneficiary of the AI build-out.

Analysis

Jabil’s setup is less about headline AI demand and more about operating leverage from mix shift plus scale. Once a manufacturing platform gets embedded in hyperscaler programs, the second-order effect is pricing power on value-added assembly, test, and integration—not just volume growth—so the earnings inflection can outlast the initial capex wave. The market is still likely underestimating how much this kind of business can re-rate when utilization improves across incremental capacity, because each turn of margin expansion drops disproportionately to EPS.

The real competitive implication is that JBL can become a gating supplier for AI infrastructure build-outs, which hurts smaller EMS peers and component vendors that lack density, qualification depth, or the balance sheet to pre-invest. That tends to create a winner-take-more dynamic: hyperscalers consolidate spend into the few suppliers capable of meeting ramp schedules, while weaker suppliers face mix deterioration and longer cash conversion cycles. If that pattern persists, the market should start valuing JBL less like a cyclical assembler and more like an infrastructure enabler with a quasi-strategic customer base.

The key risk is timing: margin expansion usually shows up slower than revenue beats, so the next 1-2 quarters matter more for sentiment than the long-term thesis. If AI capex pauses, or if a large customer pushes out deployments, the multiple could compress even if fundamentals remain intact. The other tail risk is execution—capacity adds before demand is fully locked can temporarily pressure margins and working capital, creating a short-term earnings-quality debate.

The consensus may be missing that this is not a pure top-line story; the upside comes from a sustained mix shift toward higher-complexity programs and a longer runway of incremental profitability. That makes the thesis less fragile than a single order win, but it also means the stock can keep rerating as evidence accumulates rather than on one big catalyst. In that sense, the move may still be underdone if investors are anchoring on trailing margins instead of the forward earning power of the installed capacity.

Key Decisions for Investors

• Go long JBL on pullbacks over the next 2-6 weeks; use a 3-6 month horizon and frame risk/reward as roughly 2:1 if margin expansion starts to show through in reported quarters.
• Pair trade: long JBL / short a lower-quality EMS peer basket over 1-2 quarters to express the view that hyperscaler qualification and scale advantages will concentrate share in the strongest operators.
• Buy medium-dated JBL call spreads into any post-earnings volatility; the thesis is that upside is driven by forward margin revisions, so options give better convexity than outright stock.
• If management commentary suggests capacity is ahead of demand, trim 25-30% of longs immediately; that is the clearest signal the margin bridge is at risk of slipping by one or two quarters.
• Use a watchlist trigger around the next two quarterly prints: if operating margin steps toward 6% faster than expected, add to position, because the stock should re-rate on EPS durability rather than revenue alone.